Shiguo Zhu

6PUBLICATIONS
21CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 28, 2026
Natural Killer Cell-Based Immunotherapy in HCC.

|Apr 15, 2026
Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy.

Cheng Fang, Guanglei Li, Min Han

|May 08, 2024
Traditional Chinese Medicine for Cancer Treatment.

Yangli Liu, Cheng Fang, Jiaojiao Luo

|Mar 08, 2024
Euphohelioscopin A enhances NK cell antitumor immunity through GSDME-triggered pyroptosis.

Chenyuan Gong, Hongyan Mu, Jiaojiao Luo

|Apr 19, 2021
Ze-Qi-Tang Formula Induces Granulocytic Myeloid-Derived Suppressor Cell Apoptosis via STAT3/S100A9/Bcl-2/Caspase-3 Signaling to Prolong the Survival of Mice with Orthotopic Lung Cancer.

Zi-Hang Xu, Yang-Zhuangzhuang Zhu, Lin Su

|Jan 28, 2021
Grain-sized moxibustion promotes NK cell antitumour immunity by inhibiting adrenergic signalling in non-small cell lung cancer.

Dan Hu, Weiming Shen, Chenyuan Gong

Pageof 1

Frequent Collaborators

2 joint publications

Cheng Fang

2 joint publications

Jiaojiao Luo

2 joint publications

Lixin Wang

1 joint publications

Yang-Zhuangzhuang Zhu